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ORIGINAL ARTICLE
Adipogenic human adenovirus-36 reduces leptin
expression and secretion and increases glucose uptake
by fat cells
SD Vangipuram1, M Yu1, J Tian1, KL Stanhope2, M Pasarica1,3, PJ Havel2, AR Heydari1 and
NV Dhurandhar3
1Department of Nutrition and Food Science, Wayne State University, Detroit, MI, USA; 2Department of Nutrition, University
of California, Davis, CA, USA and 3Pennington Biomedical Research Center, Baton Rouge, LA, USA
Objective: Human adenovirus Ad-36 causes adiposity in animal models and enhances differentiation and lipid accumulation in
human and 3T3-L1 preadipocytes, which may, in part, explain the adipogenic effect of Ad-36. We determined the
consequences of Ad-36 infection on leptin and glucose metabolism in fat cells.
Design: 3T3-L1 preadipocytes were used to determine the effect of infection by human adenoviruses Ad-36, Ad-2, Ad-9 and Ad-
37 on leptin secretion and lipid accumulation. Rat primary adipocytes were used to determine the effect of Ad-36 infection on
leptin secretion and glucose uptake in vitro. Furthermore, the effect of Ad-36 on expressions of leptin and selected genes of de
novo lipogenesis pathway of visceral adipose tissue were compared ex vivo, between Ad-36 infected and uninfected control rats.
Results: Ad-36 suppressed the expression of leptin mRNA in 3T3-L1 cells by approximately 58 and 52% on days 3 and 5 post-
infection, respectively. Leptin release normalized to cellular lipid content was 51% lower (Po0.002) in the Ad-36 infected 3T3-
L1 cells. Lipid accumulation was significantly greater and leptin secretion was lower for the 3T3-L1 cells infected with other
human adenoviruses Ad-9, Ad-36, or Ad-37. Whereas, human adenovirus Ad-2 did not influence cellular lipid accumulation or
the leptin release. In rat primary adipocytes, Ad-36 reduced leptin release by about 40% in presence of 0.48 (Po0.01) or 1.6 nM
insulin (Po0.05) and increased glucose uptake by 93% (Po0.001) or 18% (Po0.05) in presence of 0 or 0.48 nM insulin,
respectively. Next, the adipose tissue of Ad-36 infected rats showed two to fivefold lower leptin mRNA expression, and 1.6- to
21-fold greater expressions for acetyl Co-A carboxylase-1 and 1.2- to 6.3-fold greater expressions for fatty acid synthase, key
genes of de novo lipogenesis, compared to the uninfected weight and adiposity matched controls.
Conclusion: The in vitro and ex vivo studies show that Ad-36 modulates adipocyte differentiation, leptin production and glucose
metabolism. Whether such a modulation contributes to enhanced adipogenesis and consequent adiposity in Ad-36 infected
animals or humans needs to be determined.
International Journal of Obesity advance online publication, 16 May 2006; doi:10.1038/sj.ijo.0803366
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Introduction
The etiology of obesity is multifactorial and understanding
the contribution of various causative factors is critical for its
successful management. In addition to genetic, behavioral,
endocrinal and other factors, viral infections have been
proposed as one of the nine causative factors for obesity1 and
are recently receiving increasing attention.2,3 To date, seven
pathogens have been reported to promote adiposity in
animal models.4,5 Adenovirus type 36 (Ad-36) is the first
human virus reported to induce adiposity along with a
paradoxical relative hypolipidemia in experimentally in-
fected chickens, mice and non-human primates.6–8 Ad-36
antibodies are associated with obesity and reduced choles-
terol levels in humans.9 The prevalence of Ad-36 antibodies
was 30% in the obese compared with 11% in the non-obese
subjects screened, and the antibody positive subjects had
greater body weights but lower-serum lipids, findings similar
to those observed in the animal models.10
The absence of overt hypothalamic lesions and a positive
correlation of Ad-36 DNA quantity in adipose tissue with the
mass of that adipose depot in Ad-36 infected animals
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(unpublished observations, Dhurandhar et al.) suggested a
direct effect of the virus on adipose tissue, as opposed to a
centrally mediated mechanism of action. We recently
reported that Ad-36 enhances differentiation of 3T3-L1 as
well as human preadipocytes,11 which may, in part, explain
the in vivo adipogenic effect of Ad-36. Ad-36 infection
increased the number of adipocytes, lipid content and
activity of glycerol 3-phosphate dehydrogenase (G-3PDH),
a differentiation specific enzyme marker of adipocytes.11
Subsequent to observing the primary effect of Ad-36 on
preadipocyte differentiation process, we proceeded to in-
vestigate functional modulations in the infected adipocytes.
Production and release of adipocytokines is one of the
important functions of adipocytes. Leptin, a protein in-
volved in body weight regulation, is one of the most
extensively studied adipocytokines.12,13 During adipocyte
differentiation, leptin expression increases concomitantly
with lipid droplet accumulation.14 Leptin appears to have
paracrine feedback effects on adipocyte metabolism.15,16
Leptin stimulates lipolysis, inhibits the expression of genes
of lipid synthesis such as fatty acid synthase (FAS) and
upregulates adipocyte genes involved in lipid oxidation.17,18
Adenovirus-vector induced hyperleptinemia in rats depletes
body fat.19 Conversely, adipogenic agents like the thiazoli-
nediones and valproic acid reduce leptin secretion.20–22
Furthermore, adipocyte-selective reduction of leptin recep-
tors leads to adiposity in mice, despite a normal level of
hypothalamic leptin receptors and normal food intake.16
These findings suggest adipogenic role of hypoleptinemia.
Therefore, we hypothesized that a relative hypoleptinemia
produced locally in adipose tissue may act via autocrine/
paracrine pathway and contribute to enhanced preadipocyte
differentiation, lipid accumulation and fatty acid synthesis
in cells infected with Ad-36.11 Moreover, leptin impairs
insulin sensitivity and glucose uptake in adipocytes.23,24
Therefore, we further hypothesized that Ad-36-induced
relative hypoleptinemia will be accompanied by an increase
in glucose uptake in adipocytes.
As described below, we investigated the effect of Ad-36
infection on expression and secretion of leptin by 3T3-L1
cells and screened other human adenoviruses for similar
effects. Next, we determined the effect of Ad-36 on leptin
secretion and glucose uptake in rat primary adipocytes.
Considering the likely conversion of glucose in adipocytes to
lipids, we determined the effect on expressions of leptin and
genes of de novo lipogenesis in the adipose tissue of Ad-36
infected rats.
Research methods and procedures
Materials
Media: minimum essential media Eagle (MEM) (Cat #
M-0643, Sigma Chemicals, St Louis, MO, USA) with non-
essential amino acids, Earle’s salts and L-glutamine and 10%
fetal bovine serum (FBS, GIBCO, Carlsbad, CA, USA) was
used for growing A549 cells and Dulbecco’s modified
Eagle’s Media (DMEM) (Cat # M-0643, Sigma Chemicals)
with 10% fetal bovine serum (FBS) was used to grow 3T3-L1
cells.
Tissue culture: A549 cells (human bronchial carcinoma
cells) (ATCC Cat # CCL-185) were used for harvesting
adenoviruses and 3T3-L1 cells (ATCC, Cat # CCL-92-1) were
used for the differentiation experiments.
Virus: Ad-36 obtained from ATCC (Cat # VR-913) and
plaque purified, was used for the experiments. The titer of
virus stocks was determined as described previously.6
Experiments
Experiment 1. Leptin gene expression:. (a) Ad-36 inoculation
and differentiation of 3T3-L1 cells: 3T3-L1 cells were grown in
six-well (35 mm) plates and cultured in DMEM supplemen-
ted with 10% fetal bovine serum (FBS) and 1% antibiotic–
antimycotic (Penicillin-Streptomycin and Amphotericin B).
At confluence (day 0), the media was removed from each
well and the cells were inoculated with Ad-36 (Ad-36 group)
(multiplicity of infection, MOI 3.8) or media (Control group)
and incubated for 1 h at 371C Next, this inoculum was
replaced with 3 ml of differentiation media (MDI, containing
DMEM, and 10% bovine serum with 1 antibiotic–anti-
mycotic, 10 mg/ml insulin, 39 mg/ml dexamethasone and
115 mg/ml 3-isobutyl-1-methylxanthine). After incubation
for 48 h at 371C (day 2), the differentiation media was
replaced with 10% FBS-DMEM containing 0.001% insulin
(maintenance media). Maintenance media was replaced
every 2 days.
(b) RNA extraction: RNA was extracted from control and Ad-
36 inoculated 3T3-L1 cells on days 0, 1, 2, 3 and 5 post-
inoculation using TRIZOL reagent (Sigma cat # T-9424)
followed by chloroform treatment and RNA precipitation by
isopropyl alcohol. Residual genomic DNA was removed using
RNase-free DNase (Ambion, Austin, TX, USA). Sample RNA
concentrations and purity were determined by spectrophoto-
metry. The integrity of all RNA samples was confirmed by
electrophoresis in denaturing formaldehyde-containing gels.
This RNA was used to determine leptin mRNA level by
qualitative RT-PCR and real-time PCR assays as described below
(c and d). Separate experiments were conducted to provide
samples for the qualitative and quantitative RT-PCR assays.
(c) Leptin gene expression by qualitative RT-PCR: The follow-
ing primer pairs were designed to detect leptin mRNA by
RT-PCR using one step RT-PCR kit (Clontech RT-PCR KIT,
Cat # K1403-2).
Forward primer: 50-GGCTTTGGTCCTATCTGTCTTATGTTC-30
Reverse primer: 50-CCTGTTGATAGACTGCCAGAGTCTG-30
Six replicate samples were used for the Control and Ad-36
groups. RNA (1mg) sample was used for each reaction.
Linearity range of PCR cycle numbers was decided by
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linearity test. The following time and temperature conditions
were used for the assay: Reverse transcription: 1 h, 501C PCR:
denaturation 30 s at 941C annealing 30 s at 651C extension
1 min at 681C and final extension 2 min at 681C Inactivated
reverse transcriptase (by heating for 5 min at 951C) was used
as a negative control for every sample and 18 s rRNA
expression was used as a positive control for the assay. Leptin
gene expression was quantified using Bio-Rad Chemi-imager
(Cat # 170-8060) and normalized to 18sRNA expression.
(d) Leptin gene expression by real-time RT-PCR: Of total RNA
1 mg was reverse-transcribed to cDNA by using iScriptTM
cDNA Synthesis Kit (Cat # 170-8890, Bio-Rad, Hercules, CA,
USA) per the manufacturer’s protocol. Three replicate
samples (obtained from experiments repeated thrice) were
used for the control and Ad-36 groups. The 20 ml reactions
were incubated at 251C for 5 min, then at 421C for 30 min
followed by 851C for 5 min, to inactivate the reverse
transcriptase. The amount of leptin mRNA relative to the
b-actin endogenous control was determined using real-time,
quantitative PCR. The sequence of the leptin primers was
50-GAATGCTGAAGTTTCAAAGG-30, forward primer and
50-GGAGAGAAATGAATGATGGA-30 reverse primer of the
Leptin gene cDNA sequence. The expected product sizes for
the b-actin and leptin primers were 143 and 121 bp,
respectively. Real-time quantitative PCR was performed in
the iCycler iQ System (Bio-Rad) using SYBER Green detection
system (Cat # 170-8880, Bio-Rad).
Briefly, to 2.5ml of the 10 SYBR green buffer, 1 mM dA, dG,
dC and dUTP, 2 mM MgCl2, 0.625 U of iTaq DNA polymerase,
250 nM of the forward and reverse primer, 5ml of a 1:10
dilution of the cDNA, water was added to make 25ml. The
reactions were performed in the 96-well PCR plate covered
with optical quality sealing tape. The reactions were performed
for 40 cycles of 30 s at 951C, 30 s at 581C and 30 s at 721C.
The end point used in the real-time PCR quantification, Ct,
was defined as the PCR cycle number that crosses an arbitrarily
placed signal threshold. Water was used as a negative control.
The amount of leptin mRNA relative to b-actin was calculated
as 2DCt where Ct¼CtleptinSCtActin. As relative expression of
leptin gene in Ad-36 infected and uninfected controls was
being studied and since the genes amplified at the same rate,
no standard was used for absolute quantification.
Experiment 2. Leptin release by 3T3-L1 cells
(a) Leptin measurement: Differentiation of confluent 3T3-L1
preadipocytes (6 wells/group) was induced by MDI following
their inoculation with Ad-36 or media (control) as described
above. On day 5 post-inoculation, the supernatant media
from all the wells was removed and diluted 1:2 with assay
buffer provided with the kit (Titerzyme EIA mouse Leptin
ELISA kit, Assay Designs Inc, Cat # 900-019). Leptin levels in
the media were determined on day 5 by incubating the
diluted media with mouse leptin antibody coated in 96-well
plates for 1 h at 371C. The wells were washed thoroughly
with wash buffer and the leptin-primary antibody complex
was incubated with a secondary antibody (rabbit IgG linked
to horseradish peroxidase enzyme) for 30 min at 371C. After
thorough washing, all the wells were incubated with a
substrate solution (tetramethyl benzidine) for the horse-
radish peroxidase and incubated for 30 min at room
temperature in the dark. The Optical density was measured
at 450 nm in a micro-plate reader. The standard curve was
constructed using the standard leptin provided in the kit.
Leptin release in the media was normalized to the lipid
content of the well, which was determined as follows.
(b) Determination of cellular lipid content: Oil Red O, a lipid
specific dye stains fat cells in proportion to the accumulated
lipids and the assay is widely used to determine cellular lipid
content.25 After removing media for leptin determination as
described above, the cells were fixed for 1 h with 10%
formalin, then washed with water and stained for 2 h with
Oil Red O, followed by exhaustive rinsing with water. After
evaporating the excess water at 321C the dye was extracted
with isopropyl alcohol and its absorbance was determined at
510 nm, which was normalized to the amount of cellular
DNA in the sample. The cellular DNA of each well was
determined using the Wizard Genomic DNA Purification kit
(Promega, Cat # A-1620).
Experiment 3: Effect of other human adenoviruses on
differentiation and leptin secretion by 3T3-L1 cells
We determined if the effect of Ad-36 on differentiation and
leptin secretion by 3T3-L1 cells was common to other
subgroup D adenoviruses such as Ad-37 and Ad-9. Consider-
ing the fact that Ad-2, a subgroup C adenovirus does not
induce preadipocyte differentiation11 it was used as a
negative control, whereas Ad-36 was used as a positive
control. Confluent 3T3-l1 cells were inoculated with either
media (control), Ad-36 (MOI 3.0), Ad-9 (MOI 1.0), Ad-37
(MOI 30) or Ad-2 (MOI 2.5) and differentiated as described in
Experiment 1. Lipid accumulation in was determined by Oil
Red O method and leptin in the media was measured by
Titerzyme E1A mouse leptin ELISA kit (Assay Design, cat #
900-019) as described in Experiment 2. Lipid accumulation
was normalized to the amount of DNA and leptin was
normalized to the amount of lipid in each well.
Experiment 4 Leptin release from rat primary adipocytes
(a) Adipocyte isolation and culture. The animal protocols were
approved by the Administrative Animal Care and Use
Committee at University of California. Adipocytes were
obtained from epididymal fat pads of male Sprague–Dawley
rats (Harlan Sprague Dawley, Indianapolis, IN, USA) as
previously described.26 A brief description of the procedure
is as follows.
Adipocyte isolation and culture Adipocytes were isolated
from epididymal fat depots. Fat was minced with scissors in
HEPES buffer (pH 7.4; containing 5 mM D-glucose, 2% BSA,
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135 mM NaCl, 2.2 mM CaCl2 2H2O, 1.25 mM MgSO4 7H2O,
0.45 mM KH2PO4, 2.17 mM Na2HPO4 and 10 mM HEPES).
Adipose tissue fragments were digested in the same buffer
with type I collagenase (1.25 mg/ml per 0.5 g tissue) at 371C
with gentle shaking for 30 min. The resulting cell suspension
was diluted in HEPES-phosphate buffer, and the isolated
adipocytes were then separated from the undigested tissue
by filtration through a 400-mm nylon mesh and washed
three times. Isolated adipocytes were then re-suspended in
DMEM supplemented with 1% FBS and incubated for 40 min
at 371C. The isolated adipocytes (150 ml of 2:1 ratio of packed
cells to medium) were then plated on 500 ml of a collagen
matrix (Vitrogen 100, Cohesion Technologies) in six-well
culture plates. After 50 min of incubation at 371C, 2 ml
DMEM supplemented with 1% FBS was added to each well.
All six wells in one culture plate were seeded at equal
density with the adipocytes isolated from one animal and
inoculated with 4105 PFU Ad-36, or media (n¼7 plates per
group). After 24 h, the inoculation media was removed and
replaced with 2 ml media containing no insulin or physio-
logical concentration of insulin (0.48 or 1.6 nM). Within
each plate, there were adipocytes treated without insulin,
with insulin, with Ad-36, and with Ad-36 and insulin. The
cells were maintained in an incubator at 371C in 5% CO2 for
up to 96 h. Aliquots (300 ml) of the media were collected at
24, 48, 72, and 96 h and the sampled quantity was replaced
with fresh medium. Glucose uptake, lactate production, and
leptin secretion were determined.
(b) Assays
Leptin concentrations in the medium were determined with
a sensitive and specific RIA for rat leptin (Linco Research, St
Charles, MO, USA).27 The antibody used in the assay does
not cross-react with insulin. Glucose and lactate in the
medium were measured with an YSI glucose analyzer (model
2300, Yellow Springs Instruments, Yellow Springs, OH, USA).
Glucose uptake and lactate and leptin production were
calculated as previously described.28
Experiment 5: Leptin, FAS and ACC-1 gene expression in rat
visceral fat
(a) Experimental design. Male Wistar rats (5 weeks old) were
obtained from Harlan (Indianapolis, IN, USA) and housed in
micro isolator cages under bio-safety level two containment,
with a separate air supply to each room. Protective clothing,
gloves, shoes, hairnets and masks were used to enter the
rooms and care was taken to prevent cross contamination.
After 1 week of acclimatization to the new surroundings, rats
were randomized in two weight-matched groups (control and
infected) of 25 each and housed in separate rooms. Next the
control and infected groups were i.p. injected with 200ml of
cell culture media or Ad-36 virus suspension (B108 PFU),
respectively. Access to food (chow diet) and water was
provided ad libitum throughout the study and food consump-
tion was recorded for individual cages. Rats were weighted
weekly. After an overnight fast, animals were exsanguinated
and killed 30 weeks post-inoculation, under Pentobarbital
anesthesia. Epididymal-inguinal, retroperitoneal, and visceral
fat depots were carefully separated, weighed and flash frozen
in liquid Nitrogen. As we reported earlier,29 infected rats had
greater body weight and total fat compared to the control
group (mean7s.e.: 628.3713.0 g vs 587.578.48 g; Po0.008
and 52.3710.6 g vs 32.773.5 g; Po0.00002, respectively).
Epididymal and inguinal fat pad, retroperitoneal fat pad and
visceral fat pads were 60, 46 and 86% greater for the infected
group compared with control.29 Adipose tissue samples from
these rats were used in the current experiment to determine
the expressions of leptin, FAS and acetyl co-A carboxylase-1
(ACC1) in visceral adipose tissue of the two groups by
quantitative real-time PCR assay (qRT-PCR). To minimize
the confounding effect of different degree of adiposity on
gene expression, three pairs of animals were selected from the
two groups that matched closely in body weights and visceral
fat weights. The percentiles for body weights for these animals
were 30th, 50th and 75th from the control group, which were
compared respectively, to the 20th, 30th or the 37th
percentile from the infected group.
RNA extraction
RNA was extracted using the RNeasy Lipid Tissue Mini Kit,
including treatment with DNase I to prevent genomic DNA
contamination, strictly following the manufacturer’s instruc-
tions (Cat # 74804, Qiagen, Valencia, CA, USA). Extracted
RNA was stored at 801C until required for cDNA synthesis.
Real-time PCR was performed as described for experiment
1. The sequence of the leptin primers was 50-CACGA
CACCCTTCACCACAAG-30, forward primer and 50-TTGAGG
CAGAAGCTCCTCCA-30, reverse primer.30 FAS primers used
were: forward: 50-AGATGAAGGTGGTGGAGGTG-30 and re-
verse 50-TGCAGCTTGGTCTGAACATC-30. ACC1 primers
used were: forward 50-ACCTTACTGCCATTCCATGC-30and
reverse: 50-AAGCTTCCTTCGTGACCAGA-30. Leptin primers
used were: forward 50-CACGACACCCTTCACCACAAG-30
and Reverse 50-TTGAGGCAGAAGCTCCTCCA-30).
Statistical analysis
The effects of Ad-36 were determined by comparing the
group means with those of the uninfected controls, using
Student’s t-test. Student’s t-test with Simes correction was
used for multiple comparisons. All values were expressed as
means7s.e.m. Values of Po0.05 were considered significant.
Results
Experiment 1. Leptin gene expression
As expected, leptin mRNA was not detectable on 0, 1 and 2
days post-inoculation in either control or Ad-36 inoculated
Ad-36, leptin expression and secretion
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groups.14 An expected rise in leptin mRNA expression was
observed on day 3. Leptin mRNA expression on day 3 was
19% lower in the Ad-36 inoculated group (Po0.05) as
determined by the qualitative RT-PCR method (Figure 1).
Quantitative real-time RT-PCR analysis showed that Ad-36
suppressed leptin gene expression by approximately 58% on
day 3 (Po0.02) and by 52% on day 5 (Po0.04) compared to
the Control group (Figure 2).
Experiment 2. Leptin release by 3T3-L1 cells
As previously reported,11 lipid accumulation normalized to
the amount of DNA was significantly greater in the Ad-36
infected group (Figure 3). Leptin released in the media,
unadjusted for lipid levels for the control and Ad-36 groups
were 0.1170.02 vs 0.1170.01 absorbance at 450 nm, P¼0.7,
respectively. However, when normalized to the lipid content
of the well, the leptin release was reduced to 5178%
(Po0.002), in the Ad-36 group, compared to the control
(Figure 3).
Experiment 3. Effect of other human adenoviruses on
differentiation and leptin secretion of 3T3-L1 cells
Compared to the uninoculated control, subgroup D
viruses Ad-36, Ad-37 and Ad-9 induced significantly
greater lipid accumulation (Po0.0001; Figure 4a). When
the leptin secretion was corrected for lipid content,
Ad-36, Ad-37 and Ad-9 inoculated groups had lower leptin
secretion (Po0.002; Figure 4b) on day 5 post inoculation.
Ad-2, a Subgroup C virus did not share these effects
(Figure 4).
Figure 1 RNA was isolated on days 0, 1, 2 and 3 from uninfected control and Ad-36 infected 3T3-L1 cells. Leptin expression was determined using qualitative RT-
PCR and results were normalized to 18 s rRNA levels. (a) Although 18 s rRNA was expressed on days 1, 2 and 3, leptin mRNA expression started on day 3. (b) 18 s
rRNA and corresponding leptin expression on day 3. C1 to C6 and a1 to a6 are control and Ad-36 infected samples, respectively. (c) Comparison of leptin mRNA
expression on day 3 for Ad-36 vs the uninfected control, quantitated by a Bio-Rad chemimager. *Po0.05 compared to the uninfected control group.
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Figure 2 RNA was isolated on days 0, 2, and 3 from control and Ad-36
infected plates and tested for leptin expression using real-time RT-PCR and
results were normalized to constitutive b-actin control. The percent leptin
expression is shown relative to expression by uninfected control cells, which is
considered 1. No leptin expression was detected on day 0 in control and
infected samples. Ad-36 suppressed leptin gene expression by approximately
58% on day 3 (*Po0.02) and by 52% on day 5 (**Po0.04) compared to the
Control group.
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Experiment 4. Leptin release by rat primary adipocytes
Leptin release by primary adipocytes from the epididymal fat
pads of male Sprague-Dawley rats, inoculated with Ad-36, or
control media, was not different in the absence of insulin,
(Mean7s.e.) 14.475.0 vs 17.376.4 ng, P¼NS, (Figure 5).
However, leptin release over 96 h was significantly lower in
cells exposed to Ad-36 in presence of 0.48 nM insulin
(21.5712.2 vs 34.1713.6 ng: Po0.01) or 1.6 nM insulin
(19.375.2 vs 32.6710.2 ng: Po0.05) (Figure 5). On the
other hand, adipocytes inoculated with Ad-36 had greater
glucose uptake in the absence of insulin (12337112 vs
636754 mg: Po0.001) and in the presence 0.48 nM insulin
(1627782 vs 1389797 mg: Po0.05), but not in the presence
of 1.6 nM insulin (2078755 vs 1931771 mg: P¼NS) (Figures
6). Both lactate production (Figure 7) and the percentage of
glucose metabolized to lactate were significantly higher in
Ad-36 infected cells compared to uninfected cells (25.973.2
vs 19.773.0%, Po0.001; 25.572.9 vs 17.273.0%, Po0.01;
27.073.9 vs 20.572.8%, Po0.05 at 0, 0.48, 1.6 nM insulin
concentrations, respectively).
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Figure 3 Uninfected control and Ad-36 infected 3T3-L1 cells were
differentiated and on day 5 post-infection lipid accumulations in both groups
were determined using the Oil Red O method. Leptin secreted in to the media
was determined by ELISA and expressed as absorbance per unit lipid. Lipid
accumulation normalized to the amount of DNA was significantly greater in
the Ad-36 infected group (*Po0.05). Leptin release normalized to the lipid
content of the well was reduced to 5178% (**Po0.002), in the Ad-36 group,
compared to the control.
Figure 4 Lipid content and leptin secretion in 3T3-L1 cells infected with
human adenoviruses. (a) 3T3-L1 cells were inoculated with media, Ad-36, Ad-
37, Ad-9 or Ad-2, and differentiated with MDI. Lipid accumulation was
determined 5 days post-inoculation using the Oil Red O method, normalized
to the amount of cellular DNA in a sample and expressed as % of the
uninfected control. *Po0.0001, compared to the uninfected control group.
(b) 3T3-L1 cells were inoculated with media, Ad-37, Ad-37, Ad-9 or Ad-2,
differentiated with MDI. Leptin secreted in to the media on day 5 was
determined by ELISA and expressed as absorbance per unit lipid. **Po0.002,
compared to the uninfected control group.
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Figure 5 Leptin secretion over 96 h by cultured rat primary adipocytes pre-
incubated for 24 h in the presence and absence of Ad-36. Data expressed as
mean7s.e.m. *Po0.05, **Po0.01 Ad-36 vs No virus, n¼ 7.
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Figure 6 Glucose utilization over 96 h in cultured rat primary adipocytes
pre-incubated for 24 h in the presence and absence of Ad-36. Data expressed
as mean7s.e.m. **Po0.01, ***Po0.001 Ad-36 vs No Adenovirus, n¼7.
Ad-36, leptin expression and secretion
SD Vangipuram et al
6
International Journal of Obesity
Experiment 5: Leptin, FAS and ACC1 expression in rat visceral
fat
Leptin expression was 0.2, 0.6 and 0.5 fold lower in infected
compared to the control rats that were matched for body
weight and visceral fat weight, 30 weeks post-inoculation
(Table 1). Interestingly, in the same pairs FAS and ACC1
expression was increased in the Ad-36 infected rats, indicat-
ing increased de novo lipogenesis despite similar body fat.
Discussion
Ad-36 is the first human adenovirus reported that causes
obesity in experimentally infected animals and shows
association with human obesity. It was first isolated from
fecal sample of a diabetic girl suffering from enteritis.31 In
the United States, 30% of the obese but only 11% of the non-
obese subjects showed antibodies to Ad-36. Although a
human pathogen, Ad-36 is remarkably unselective about its
choice of host. We have reported experimental infection of
chickens, mice, rats and marmosets6–8,29 and natural infec-
tion in rhesus monkeys8 with Ad-36. We have reported
transmission of Ad-36 infection by blood transfusion.6 Not
much more is known about the transmission routes of the
virus. In experimentally infected animals, Ad-36 increases
adiposity, without other overt signs and symptoms.
Mechanism of Ad-36 induced adiposity is unknown.
Promotion of preadipocyte differentiation by Ad-3611 may
contribute to its adipogenic effect, a finding that prompted
us to investigate consequential effects of the virus-induced
differentiation on key metabolic and biochemical functions
of adipocytes. This study focused on the effect of Ad-36 on in
vitro expression and secretion of leptin, and the related
modulations in glucose handling by the adipocytes.
Like primary adipocytes, leptin is also expressed in and
released by 3T3-L1 cells (murine-embryo-derived cell line),32
albeit in low quantities and the cell line has been used for
studying the regulation of leptin expression and secretion.33–
35 Similar to the observations of others,34 we also observed
leptin expression 3 days after induction of differentiation of
3T3-L1 preadipocytes. Quantitative RT-PCR confirmed that
leptin mRNA expression is lower in the virus-infected group.
We hypothesized that the observed reduction in leptin
mRNA would result in reduced leptin protein secretion into
the media, which was determined in Experiment 2.
Rates of leptin secretion in vitro have been shown to
strongly correlate with leptin mRNA levels (r¼0.89,
Po0.001).36 Considering the continued relative suppression
of leptin expression by Ad-36 on day 5 (Figure 2), and to
allow its adequate production and release, leptin release by
3T3-L1 cells was determined on day 5 post-inoculation
(Experiment 2). Leptin levels were within the detectable
range of the standard curve.
Leptin released in the media was adjusted to the lipid
content of the wells for the following reasons. It is well
known that leptin levels strongly correlate with the amount
of lipid37,38 and its release is proportional to adipocyte
volume.36 Compared to the uninfected control, the virus
increases differentiation of 3T3-L1 cells,11 resulting in greater
proportion of adipocytes and the lipid content. As adipo-
cytes, but not preadipocytes secrete leptin, it would be
misleading to compare leptin secretion of two groups
containing unequal number or size of adipocytes. Therefore,
as previously practiced by others,39 leptin secretion was
normalized to the amount of cellular lipid. Experiment 3
used rat primary adipocytes seeded at equal density. There-
fore, there was no need to normalize leptin secretion to
adipocytes in this experiment. Even without normalization
for lipid content, leptin secretion in the virus inoculated
group was lower in presence of insulin.
0.0 0.5 1.0 1.5 2.0
0
250
500
750 Ad-36
No virus 
***
***
*
Insulin (nM)
La
ct
at
e 
(µg
)
Figure 7 Lactate production over 96 h in cultured rat primary adipocytes
pre-incubated for 24 h in the presence and absence of Ad-36. Data expressed
as mean7s.e.m. *Po0.05, ***Po0.001 Ad-36 vs No virus, n¼7.
Table 1 Leptin, FAS and ACC-1 expression in rat visceral fat
Pair 1 Pair 2 Pair 3
Control Infected Control Infected Control Infected
Body weight (g) 567 569 613 612 591 598
Visceral fat 7.9 8.1 9.3 11.3 10.7 11.7
Leptin 1.0 0.2 1.0 0.6 1.0 0.5
FAS 1.0 1.23 1.0 6.34 1.0 2.19
ACC-1 1.0 1.58 1.0 4.0 1.0 21.11
One group of male Wistar rats were infected with Ad-36 (Infected group) and
the other group was uninfected control. Animals were sacrificed 7 months
later as reported earlier.29 To minimize the confounding effect of different
degree of adiposity on gene expressions, 3 pairs of animals were selected from
the two groups that matched closely in body weights and visceral fat weights.
Expressions of leptin, FAS and ACC-1 were determined by qRT-PCR,
normalized to b-actin and expressed as a fold difference in the Infected
animals compared to the Control. Expression in the Control group was
considered to be 1. Body weight and visceral fat weights are at the time of
killing. In rats from the infected group, leptin expression showed a significant
decrease (P¼ 0.026), where as the increase in ACC-1 and FAS did not reach
statistical significance (P40.05).
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Consistent and complementary results were obtained in
these independently conducted studies (Experiments 1 and
2), which collectively demonstrated that leptin expression
and secretion were inhibited in cells infected with Ad-36. It is
noteworthy that only (an unknown) fraction of the cells
from Ad-36 group is likely to be infected. Apparently, the
modulation induced by Ad-36 in infected cells is robust
enough to produce significant reductions of leptin expres-
sion and secretion.
Although reduced leptin expression and secretion in
presence of increased adiposity is an apparent paradox, our
findings are very similar to those recently reported by Guo
et al.,40 who showed that genetic, diet-induced or age-related
obesity is associated with decreased leptin gene expression
per unit fat mass, compared to their respective lean counter-
parts. Lower plasma leptin concentrations per unit fat mass
have been reported in humans as well.41,42 Adenovirus-
vector induced hyperleptinemia in rats depletes body fat.19
Conversely, adipocyte-selective reduction of leptin receptors
leads to adiposity in mice, despite a normal level of
hypothalamic leptin receptors and normal food intake.16
Therefore, we postulate that a relative hypoleptinemia may
contribute to enhanced preadipocyte differentiation and
lipid accumulation in Ad-36 infected rats.
Atkinson et al.43 showed that Ad-37, but not Ad-2 increases
adiposity in animals. Ad-36, Ad-37 and Ad-9 belong to
subgroup D, whereas Ad-2 is a subgroup C human adeno-
virus. Experiment 3 determined if increased lipid accumula-
tion and decreased leptin secretion is a subgroup D
characteristic. All subgroup D adenoviruses tested increased
lipid accumulation in 3T3-L1 cells, but reduced leptin
secretion. It appears that viruses that increase adiposity in
animal models (Ad-36 and Ad-37) modulate lipid accumula-
tion and leptin secretion by adipocytes, which may be
contributing to their adipogenic effect observed in vivo.
Whereas Ad-2, a non-adipogenic virus, does not share this
property. These suggested that the adipogenic potential of
Ad-36, Ad-37 and Ad-9 could be a subgroup characteristic.
Also, the results demonstrated that adipogenic and hypo-
leptinemic properties are not common to all human
adenoviruses.
Considering the close relationship of leptin with glucose
uptake and metabolism,26,28 Experiment 4, investigated the
effect of Ad-36 on glucose uptake. Adipocytes, instead of
preadipocytes were used to obtain a sizable effect on glucose
uptake. Ad-36 affected adipocyte glucose metabolism; in-
creased glucose uptake, lactate production and the percent of
glucose metabolized to lactate. Decrease in leptin production
was not due to shutting down of cellular metabolic activity
due to viral infection. In fact, increased cellular metabolic
activity was evidenced from increased glucose uptake and
the lactate levels. Moreover, the effect was not due to
desensitization of cells to insulin during the incubation
period. In a dose–response comparison using physiologically
relevant concentrations of insulin used in this study, the
rates of glucose uptake and leptin secretion increase more
steeply during the final 48 h of culture compared to the first
48 h (data not presented). The same was true for glucose
uptake and leptin secretion from the adipocytes cultured
with and without Ad-36 in presence of 1.6 nM insulin (data
not presented).
Effects of insulin to stimulate leptin gene transcription,
mRNA expression, and secretion are mediated by the
increases of adipocyte glucose utilization,26,28 and more
specifically to its effect to shift the metabolism of glucose
away from anaerobic metabolism to lactate.44 Thus, certain
agents that increase the uptake of glucose, can concurrently
induce an inhibition of leptin secretion from cultured
primary adipocytes, if the compound also increases the
proportion of glucose anaerobically metabolized to lactate.44
Therefore, it is possible that inhibition of insulin-mediated
leptin secretion induced by Ad-36 was a result of its effect to
increase anaerobic glucose metabolism. However, there was
no statistical relationship between the decrease in leptin
secretion and increase in lactate production or percentage of
glucose metabolized to lactate induced by Ad-36 within each
dose of insulin or across all doses (r¼0.02–0.20, P¼0.4–0.9).
Thus, these data suggest that the inhibition of leptin
production induced by Ad-36 is independent of its effects
on adipocyte metabolism. It is possible that Ad-36 infection
induces a direct inhibition of leptin gene transcription.
The mechanism of modulation of leptin and glucose
metabolism by Ad-36 unclear. This study was not designed to
determine whether reduced leptin production has a causal
role in promoting in vitro adipogenesis. It is conceivable that
a relative decrease in leptin in the Ad-36 infected cells leads
to attenuation of the usual lipolytic effects of leptin,
resulting in increased preadipocyte differentiation and lipid
accumulation. Furthermore, it is possible that increased
glucose uptake by Ad-36 infected adipocytes could contri-
bute to greater lipid accumulation if, it also increases de novo
lipogenesis. Attenuation of leptin production in Ad-36
infected animals may also lead to increased adiposity
through increased food intake, decreased energy expenditure
or both.12,45 Effect of CDV (Canine Distemper virus), an
adipogenic virus, on leptin network has been previously
reported by Bernard et al.46 Expression of the long leptin
receptor isoform, was downregulated in the hypothalami of
obese mice,46 which is postulated to contribute to CDV-
induced adiposity. Effect, if any, of Ad-36 on hypothalamic
leptin receptors is unknown. Unlike Ad-36, CDV primarily
affects the CNS. Previous experiments did not show any
overt hypothalamic lesions in Ad-36-infected animals
(Dhurandhar et al., unpublished observations). Therefore,
this study focused on peripheral effects of Ad-36.
Experiment 5 was conducted to obtain preliminary
evidence for the effects of Ad-36 infection on leptin and
adipose glucose metabolism ex vivo. Earlier, we reported
increased adiposity in male Wistar rats infected with Ad-
36.29 We used adipose tissue from this rat study for
Experiment 5 to determine the effect of Ad-36 on expression
of leptin and genes of de novo lipogenesis. As the amount of
Ad-36, leptin expression and secretion
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circulating leptin is proportional to body fat, ideally such a
comparison should be made between Ad-36 infected and
uninfected animals of similar body fat content. Therefore,
we compared three pairs from the two groups, matched as
closely as possible for adiposity and body weights. Reduc-
tions in adipose tissue leptin expression and enhanced
expression of genes of de novo lipogenic pathway observed
in this ex vivo experiment (Experiment 5) are in congruence
with the in vitro data. It is possible that Ad-36 promotes
increased glucose uptake in adipocytes, which is converted
to lipids via the upregulated de novo lipogenic pathway.
Vector-induced hyperleptinemia reduces ACC-1 and FAS
mRNA.47 Therefore, the upregulation of ACC-1 and FAS in
presence of relative hypoleptinemia may be expected.
It should be pointed out that circulating leptin levels of
rats described in Experiment 529 were significantly greater
for the Ad-36-infected group. Reduction in adipose tissue
leptin expression but greater circulating leptin seems para-
doxical. However, it should be noted that the Ad-36-infected
rats had significantly greater amount of fat (29 52711 vs
3376 g, Po0.00001). It is likely that the net effect of greater
adiposity is increased plasma leptin levels compared to the
lean group, despite reduced leptin expression per unit
adipose tissue. In future, it would be important to compare
circulating leptin levels of Ad-36-infected animals with those
with similar degree of adiposity.
Circulating leptin levels have not been examined in
humans who are sero-positive for Ad-36. Subjects with
relative hypoleptinemia have lower-serum cholesterol com-
pared to relatively hyperleptinemic subjects with similar
BMI.48 Similarly, it is noteworthy that relative hypocholes-
terolemia is caused by Ad-36 in animal models6–8 and it is
associated with the presence of Ad-36 antibodies in hu-
mans.10 It is unknown whether subjects with relative
hypoleptenemia and hypocholesterolemia48 have a higher
prevalence of sero-passivity for Ad-36. In such studies, it
would be important to compare the leptin levels in Ad-36
sero-positive and control subjects with comparable adiposity
and patterns of body fat distribution.
In conclusion, these in vitro experiments demonstrate that
Ad-36 downregulates leptin expression and secretion in 3T3-
L1 cells, as well as leptin secretion from primary adipocytes.
Furthermore, the data suggest that Ad-36 increases de novo
lipogenesis in adipocytes by Ad-36. Future studies should
investigate whether an inhibition of leptin production
contributes to enhanced adipogenesis or positive energy
balance and therefore to obesity in Ad-36 exposed animals
and humans.
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